Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed both its biotech peers and the broader market since 2022. The company dominates the cystic fibrosis market and is ...
Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...
Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Back in my guiding days, friends and I often spent our days off not in pursuit of bass, trout, walleyes, or even giant muskies. Nope. On those rare days between paid trips, the most enjoyable way to ...
Where I grew up, trout were king. Over a dozen trout streams were less than 20 minutes from my New England home, all of which contained a variety of both wild and stocked rainbows, brookies, and ...
After hours: February 19 at 5:22:32 PM EST Loading Chart for VERX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback